Evergen Pushing the Boundaries of Tissue Engineering in Regenerative Medicine
Evergen, formerly known as UF startup RTI Surgical, is advancing innovative tissue engineering solutions in regenerative medicine.
Evergen Launches AI-Powered Bone Graft Image Processing Software Developed in Partnership With University of Florida
Evergen, a leading CDMO and formerly known as RTI Surgical, a UF startup, announces the launch of new AI-powered image processing software to enhance the analysis of CT bone graft scans.
RTI Surgical Transforms Into Evergen, a Leading CDMO in Regenerative Medicine
UF startup RTI Surgical unveils its new corporate identity as Evergen, signaling its strategic evolution into a premier Contract Development and Manufacturing Organization (CDMO) providing biosolutions in regenerative medicine.
RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction
UF Startup RTI Surgical announced the enrollment of the first patient in ADMIRE, a study designed to confirm the safety and effectiveness of Cortiva® Allograft Dermis in implant-based breast reconstruction.
RTI Surgical Completes Acquisition of Collagen Solutions
UF Startup RTI Surgical, a leading CDMO pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine, announced it has successfully completed the acquisition of Collagen Solutions, a premier global supplier of engineered medical-grade collagen and xenograft tissue.
RTI Surgical Completes $15M Facility Expansion in Florida for Class III Medical Devices
UF Startup RTI Surgical, a contract development and manufacturing organization has announced the completion of a new $15 million, 5,000 sq-ft Class III medical device facility in Alachua, Florida, aiming to meet rising demand in the regenerative medicine sector.
RTI Surgical Announces Agreement To Acquire Collagen Solutions
UF Startup RTI Surgical announced that it has entered into an agreement to acquire Collagen Solutions, a premier global supplier of engineered medical-grade collagen and xenograft tissue with applications in cardiac, sports medicine and orthopedics.
RTI Surgical Has a New Chief Commercial Officer
UF startup RTI Surgical has appointed Chad Croasdale as chief commercial officer for his more than 20 years of commercial and financial experience in the medtech industry.
UF Accelerate Alumni RTI Surgical Completes Acquisition of Cook Biotech
UF Innovate | Accelerate alumni company RTI Surgical, a surgical implant company, has finalized its acquisition of Cook Biotech, a life sciences company based in West Lafayette, Indiana. The company is now the only regenerative medicine company with a portfolio of both allograft and xenograft biomaterials available at scale.
UF Accelerate Alumni RTI Surgical Acquires Cook Biotech
UF Innovate | Accelerate alumni company RTI Surgical, a surgical implant company, has acquired Cook Biotech, a life sciences company based in West Lafayette, Indiana. The company is part of Cook Group, a diverse company employing 12,000 people around the world.
RTI Surgical specializes in allograft tissue processing and sterilization, innovation, regulatory know-how, and reliable manufacturing methods. The company will be combining this with Cook's cutting-edge devices that convert porcine tissue into xenograft biomaterial in order to create the best care for patients.
